Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal.
There is increasing interest in the role of asymptomatic infection in transmission of Visceral Leishmaniasis (VL). We studied the individual, household and environmental factors associated with asymptomatic Leishmania donovani infected individuals and VL. 7,538 individuals living in VL endemic villages in India and Nepal were divided into three mutually exclusive groups based on their VL history and Direct Agglutination Test (DAT) results in yearly serosurveys over a two-year period. The groups were (1) VL cases, (2) asymptomatically infected individuals (seroconverters) and (3) seronegative individuals. VL cases and seroconverters were compared to seronegative individuals in mixed logistic regression models. The risk of seroconversion and disease was significantly increased in individuals aged 14 to 24 years old and by the presence of other DAT-positive, asymptomatically infected individuals and VL cases in the house. The risk of seroconversion was higher in Indian than in Nepalese villages and it increased significantly with age, but not so for VL. This study demonstrates that, when risk factors for leishmanial infection and VL disease are evaluated in the same population, epidemiological determinants for asymptomatic infection and VL are largely similar.
Barcelona Centre for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain.
Albert
A
Picado
Institute of Tropical Medicine, Antwerp, Belgium.
Bart
B
Ostyn
Banaras Hindu University, Varanasi, India.
Shri Prakash
SP
Singh
BP Koirala Institute of Health Sciences, Dharan, Nepal.
Surendra
S
Uranw
Institute of Tropical Medicine, Antwerp, Belgium.
Epco
E
Hasker
BP Koirala Institute of Health Sciences, Dharan, Nepal.
Suman
S
Rijal
Banaras Hindu University, Varanasi, India.
Shyam
S
Sundar
Institute of Tropical Medicine, Antwerp, Belgium.
Marleen
M
Boelaert
Geneva University Hospitals, Geneva, Switzerland.
François
F
Chappuis
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007194:India / Q000453:epidemiology; D007223:Infant; D007231:Infant, Newborn; D007893:Leishmania donovani; D007898:Leishmaniasis, Visceral / Q000097:blood / Q000453:epidemiology / Q000276:immunology; D008297:Male; D008954:Models, Biological; D009390:Nepal / Q000453:epidemiology; D012307:Risk Factors